Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Rosenblatt Michael Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Rosenblatt Michael (Director) has filed a Form 4 on Axcella Health Inc.
Txns: Granted 40,000 options to buy @ $1.7, valued at $68k
05/23/2022 3 Rosenblatt Michael (Director) has filed a Form 3 on Axcella Health Inc.
05/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2021 4 Rosenblatt Michael (Director) has filed a Form 4 on Brooks Automation, Inc.
Txns: Sold 2,831 shares @ $114.13, valued at $323.1k
05/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2021 4 Rosenblatt Michael (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $23.25, valued at $581.3k
02/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2020 4 Rosenblatt Michael (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $6.22, valued at $155.5k
02/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2019 4 Rosenblatt Michael (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $16.27, valued at $406.8k
02/11/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/11/2018 4 Rosenblatt Michael (Director) has filed a Form 4 on BROOKS AUTOMATION INC
Txns: Granted 1,018 shares @ $0
09/11/2018 3 Rosenblatt Michael (Director) has filed a Form 3 on BROOKS AUTOMATION INC
07/18/2018 4 Rosenblatt Michael (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $23, valued at $575k
07/17/2018 3 Rosenblatt Michael (Director) has filed a Form 3 on Rubius Therapeutics, Inc.
05/12/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/08/2013 4 Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 4 on Merck & Co. Inc.
Txns: Exercised 4,479 shares @ $0
Paid exercise price by delivering 2,323 shares @ $44.98, valued at $104.5k
Granted 48,309 options to buy @ $44.98, valued at $2.2M
Exercised 4,479 restricted stock units @ $44.98, valued at $201.5k
02/27/2013 4 Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 4 on Merck & Co. Inc.
Txns: Granted 5,392 shares @ $42.52, valued at $229.3k
05/04/2012 4 Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 4 on Merck & Co. Inc.
Txns: Granted 3,818 restricted stock units @ $0
Granted 54,845 options to buy @ $39.29, valued at $2.2M
05/06/2011 4 Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 4 on Merck & Co. Inc.
Txns: Granted 4,103 restricted stock units @ $0
Granted 55,970 options to buy @ $36.56, valued at $2M
05/11/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
02/22/2010 4 Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 4 on Merck & Co. Inc.
Txns: Granted 15,000 restricted stock units @ $0
Granted 20,000 options to buy @ $37.49, valued at $749.8k
12/16/2009 3 Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 3 on Merck & Co. Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy